Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases

Respir Med Res. 2023 Nov 30:85:101070. doi: 10.1016/j.resmer.2023.101070. Online ahead of print.

¹ Pneumology Department, Hôpital de la Croix-Rousse, Hospices civils de Lyon, Université Claude Bernard, Lyon et CRISALIS / F-CRIN INSERM Network, France.
² Pneumology Department, Hôpital de la Croix-Rousse, Hospices civils de Lyon, Université Claude Bernard, Lyon et CRISALIS / F-CRIN INSERM Network, France. Electronic address: gilles.devouassoux@chu-lyon.fr.
³ Internal Medicine Department, Hôpital de la Croix-Rousse, Hospices civils de Lyon, France.

No abstract available

Keywords: Benralizumab; Dupilumab; EGPA; Eosinophilic granulomatosis with polyangiitis; Mepolizumab; Severe asthma.

Publication types